Systemic bevacizumab leads to resolution of diabetic macular edema.
The purpose of this study is to report a case of diabetic macular edema that resolved after systemic bevacizumab. This is an observational case report of a patient with diabetic macular edema. After initiation of systemic bevacizumab for a central nervous system glioblastoma, the diabetic macular edema resolved. Systemic bevacizumab may result in the resolution of macular edema secondary to diabetes.